LncRNA RBM5-AS1 Promotes Osteosarcoma Cell Proliferation, Migration, and Invasion

por Deng, Biyong, Pan, Runsang, Ou, Xin, Wang, Taizhe, Wang, Weiguo, Nie, Yingjie, Chen, Houping
Publicado 2021

Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2

por Pan, Runsang, Lu, Qiaoying, Ren, Chong, Li, Hao, Zeng, Fanqiang, Tian, Xiaobin, Chen, Houping
Publicado 2021

Suppression of CLEC3A inhibits osteosarcoma cell proliferation and promotes their chemosensitivity through the AKT1/mTOR/HIF1α signaling pathway

por Ren, Chong, Pan, Runsang, Hou, Lisong, Wu, Huaping, Sun, Junkang, Zhang, Wenguang, Tian, Xiaobin, Chen, Houping
Publicado 2020

MicroRNA-145-5p inhibits osteosarcoma cell proliferation by targeting E2F transcription factor 3

por Li, Hao, Pan, Runsang, Lu, Qiaoying, Ren, Chong, Sun, Junkang, Wu, Huaping, Wen, Jing, Chen, Houping
Publicado 2020

CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP‐9/PI3K/AKT pathway

por Chen, Houping, Pan, Runsang, Li, Hao, Zhang, Wenguang, Ren, Chong, Lu, Qiaoying, Chen, Hui, Zhang, Xiangyan, Nie, Yingjie
Publicado 2021

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy

por Pan, Runsang, Pan, Feng, Zeng, Zhirui, Lei, Shan, Yang, Yan, Yang, Yushi, Hu, Chujiao, Chen, Houping, Tian, Xiaobin
Publicado 2022